Loading...
Symbols:
Loading...
Symbols:
Bayer Aktienges Ads (BAYRY.PK)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Bayer Aktienges Ads (BAYRY.PK)
37 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on BAYRY.PK
- Centient Biotech Investor(6)
- Stockerblog (3)
- SA Editor Judy Weil(2)
- Aaron F. Barkoff(2)
- SA Editor Eli Hoffmann(2)
Most popular authors
(tracked in watchlists)
- SA Editor Eli Hoffmann(379)
- SA Editor Judy Weil(165)
- Stockerblog (157)
- Geoff Considine(154)
- Paul Kedrosky(142)
Most commented on authors
- SA Editor Eli Hoffmann(10)
- Todd Sullivan(5)
- Stockerblog (4)
- David Hunkar(2)
- Centient Biotech Investor(2)
- Pharmas and Biotech: Vying for Outsize Insulin Profits
- Largest German Companies Trading in the U.S.
- Reality Check on the Big Pharma Rumor Mill
- Wall Street Breakfast: Must-Know News
- Are Pfizer and Lilly's ED Drugs Suffering from the Economic Slowdown?
- Ten Highest Yielding Pharma Stocks
- Wall Street Breakfast: Must-Know News
- OTC Market Offers Relief From Sarbanes-Oxley - Barron's
- Barr Labs Prevails Over Bayer in Yasmin Case
- Bayer's Deadly Drug Poses Challenge to FDA Safety Policies
- Jatropha Being Developed as a New Biodiesel Source
- Bayer Prevails Over Dr. Reddy's in Avelox Case
- Another Safety Review on Tap for Bayer's Trasylol -- FDA Panel
- Are Public Companies Wasting Domain Name Assets?
- Bayer Ready to Cure Investors’ Headaches -- Barron’s
- Medtronic Sales Fall Short
- Bayer Buyout Rumors Materialize Again
- Pet Stocks: Nine Ways to Make Money From Caring for Your Pets
- Estimating Future Stock Returns
- Eight Value Stock Picks from Audrey Kaplan of Rochdale Investment Management
- Bayer Drug Bests Sanofi-Aventis's Lovenox in Study
- In-Line With Strategy, Dow Chemical Acquires Bayer's Cellulose Business
- Carbon Emission Disclosure: Public Companies 'Come Clean'
- 3 Rising Impotence Stocks
- Companies Provide Hormone Therapy Options for Women
- Will Bayer Buy Onyx, Its Nexavar Partner?
- Biotech Week in Review: Onyx Is Star of the Week
- Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results
- Biotech Day In Review: Merger Monday
- Onyx Doubles on Positive Cancer Drug News
- Say Ach Ya To Germany: A Global Powerhouse
- Nuvelo Plummets Over 80% After Drug Trials Fail
- Big Pharma's Big Decision: Diversify Or Focus?
- Bayer Beats Estimates Following Schering AG Acquisition
- Schering Plough is a New Beast (SGP)
- Nexavar (aka, Sorafenib) Phase 3 Data Released at ECCO (ONXX, BAY, PFE)
-
Stocks Covered by The Biotech Stock Blog
on Oct 11, 2005
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Trading Center
- Free E-Newsletters
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Advertise With Us
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Legal
- Terms of Use
- Privacy
- Copyright